Xiaolei Wang



Professor, Lanzhou University

Representative Publications

1. Wang, X.; Krasnova, L.; Wu, K. B.; Wu, W.-S.; Cheng, T.-J.; Wong, C.-H. Bioorganic & medicinal chemistry letters. 2018, 28, 2708. "Towards new antibiotics targeting bacterial transglycosylase: Synthesis of a Lipid II analog as stable transition-state mimic inhibitor"

2. Ma, Z.; Wang, X.; Wang, X.; Gao, S.; Tan, X.; Ma, Y.; Chen, C. Science (Co-first auhor, Highlighted in C&EN News). 2014, 346, 219,"Asymmetric Syntheses of Sceptrin and Massadine and Evidence for Biosynthetic Enantiodivergence"

3. Wang, X.; Gao, Y.; Ma, Z.; Rodriguez, R. A.; Yu, Z.-X.; Chen, C. Org. Chem. Front, 2015, 2, 978. “Syntheses of Sceptrins and Nakamuric Acid and Insights into the Biosyntheses of Pyrrole–Imidazole Dimers”

4. Wang, X.; Moon, J.; Dodge, M. E.; et al.; Chen, C. J. Med. Chem. 2013, 56, 2700. "The Development of Highly Potent Inhibitors for Porcupine"

5.Wang, X.; Wang, X; Tan, X.; Lu, J.; Cormier, K. W.; Ma, Z.; Chen. C.  J. Am. Chem.Soc. 2012, 134, 18834. “A Biomimetic Route for the Construction of the [4+2] and [3+2] CoreSkeletons of the Dimeric Pyrrole-Imidazole Alkaloids and the AsymmetricSynthesis of Ageliferins”







2006, Dept. of Chemistry, Lanzhou  University, B.Sc.

2011, Lanzhou University, Ph.D

2011-2015, Postdoctoral Scholar UT Southwestern Medical Center, USA

2015-2017, Research Associate The Scripps Research Institute, USA